The procedure in Patel's phase 1 Food and Drug Administration (FDA) clinical trials include mixing the "extracellular matrix" powder - a mixture of proteins and molecules isolated from heart muscle - with saline or water, injecting the mixture into the patient's dead heart muscle, and waiting three-tosix months to see if the patient's heart muscle regenerates.
Read More...